The interferon regulatory factor 5 gene confers susceptibility to rheumatoid arthritis and influences its erosive phenotype

Annals of the Rheumatic Diseases

Volumn 70, Issue 1, 2011, Pages 117-121

  Dawidowicz, Karen ^a,b   Allanore, Yannick ^c   Guedj, Mickaël ^d   Pierlot, Céline ^a   Bombardieri, Stefano ^e   Balsa, Alejandro ^f   Westhovens, René ^g   Barrera, Pilar ^h   Alves, Helena ⁱ   Teixeira, Vitor Hugo ^a,j   Petit Teixeira, Elisabeth ^a   Van De Putte, Leo ^h   Van Riel, Piet ^h   Prum, Bernard ^d   Bardin, Thomas ^c   Meyer, Olivier ^b   Cornélis, François ^a,c,k   Dieudé, Philippe ^a,b  

^a University of Evry Val d'Essonne   (France)

^b BICHAT HOSPITAL   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d UNIVERSITÉ D EVRY VAL D ESSONNE   (France)

^e UNIVERSITY OF PISA   (Italy)

^f HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^g UNIVERSITY OF LEUVEN   (Belgium)

^h RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

ⁱ HOSPITAL DE SÃO JOÃO   (Portugal)

^j UNIVERSITY OF COIMBRA   (Portugal)

^k Clinique de Genetique Medicale   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUTOIMMUNITY; BONE EROSION; CAUCASIAN; FEMALE; GENE; GENETIC LINKAGE; GENETIC MARKER; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HAPLOTYPE; HUMAN; INTERFERON REGULATORY FACTOR 5 GENE; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ARTHRITIS, RHEUMATOID; FEMALE; GENETIC LINKAGE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INTERFERON REGULATORY FACTORS; LINKAGE DISEQUILIBRIUM; MALE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RHEUMATOID FACTOR; YOUNG ADULT;

EID: 78650678904     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2010.129171     Document Type: Article

References (30)

1. Rönnblom LE, Alm GV, Oberg KE. Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors. Ann Intern Med 1991 ; 115 : 178-83 .
2. Baechler EC, Batliwalla FM, Karypis G, et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A 2003 ; 100 : 2610-15 .
3. Gottenberg JE, Cagnard N, Lucchesi C, et al. Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome. Proc Natl Acad Sci U S A 2006 ; 103 : 2770-5 .
4. Baechler EC, Batliwalla FM, Reed AM, et al. Gene expression profi ling in human autoimmunity. Immunol Rev 2006 ; 210 : 120-37 .
5. Tan FK, Zhou X, Mayes MD, et al. Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients. Rheumatology (Oxford) 2006 ; 45 : 694-702 .
6. Graham RR, Kozyrev SV, Baechler EC, et al. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet 2006 ; 38 : 550-5 .
7. Sigurdsson S, Nordmark G, Göring HH, et al. Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am J Hum Genet 2005 ; 76 : 528-37 .
8. Miceli-Richard C, Comets E, Loiseau P, et al. Association of an IRF5 gene functional polymorphism with Sjögren's syndrome. Arthritis Rheum 2007 ; 56 : 3989-94 .
9. Han SW, Lee WK, Kwon KT, et al. Association of polymorphisms in interferon regulatory factor 5 gene with rheumatoid arthritis: a metaanalysis. J Rheumatol 2009 ; 36 : 693-7 .
10. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. N ature 2 007; 447: 6 61- 7 8.
11. Graham RR, Kyogoku C, Sigurdsson S, et al. Three functional variants of IFN regulatory factor 5 (IRF5) defi ne risk and protective haplotypes for human lupus. Proc Natl Acad Sci U S A 2007 ; 104 : 6758-63 .
12. Dideberg V, Kristjansdottir G, Milani L, et al. An insertion-deletion polymorphism in the interferon regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases. Hum Mol Genet 2007 ; 16 : 3008-16
13. Kristjansdottir G, Sandling JK, Bonetti A, et al. Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations. J Med Genet 2008 ; 45 : 362-9 .
14. Nordmark G, Kristjansdottir G, Theander E, et al. Additive effects of the major risk alleles of IRF5 and STAT4 in primary Sjögren's syndrome. Genes Immun 2009 ; 10 : 68-76 .
15. Dieude P, Dawidowicz K, Guedj M, et al. Phenotype-haplotype correlation of IRF5 in systemic sclerosis: role of 2 haplotypes in disease severity. J Rheumatol 2010 ; 37 : 987-92 .
16. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classifi cation of rheumatoid arthritis. Arthritis Rheum 1988 ; 31 : 315-24 .
17. Terwilliger JD, Ott J. A haplotype-based 'haplotype relative risk' approach to detecting allelic associations. Hum Hered 1992 ; 42 : 337-46 .
18. O'Connell JR, Weeks DE. PedCheck: a program for identifi cation of genotype incompatibilities in linkage analysis. Am J Hum Genet 1998 ; 63 : 259-66 .
19. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993 ; 52 : 506-16 .
20. Kruglyak L, Daly MJ, Reeve-Daly MP, et al. Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet 1996 ; 58 : 1347-63 .
21. Laird NM, Horvath S, Xu X. Implementing a unified approach to family-based tests of association. Genet Epidemiol 2000 ; 19 (Suppl 1) : S36 - 42.
22. Rueda B, Reddy MV, González-Gay MA, et al. Analysis of IRF5 gene functional polymorphisms in rheumatoid arthritis. Arthritis Rheum 2006 ; 54 : 3815-19 .
23. Sigurdsson S, Padyukov L, Kurreeman FA, et al. Association of a haplotype in the promoter region of the interferon regulatory factor 5 gene with rheumatoid arthritis. Arthritis Rheum 2007 ; 56 : 2202-10 .
24. Dieguez-Gonzalez R, Calaza M, Perez-Pampin E, et al. Association of interferon regulatory factor 5 haplotypes, similar to that found in systemic lupus erythematosus, in a large subgroup of patients with rheumatoid arthritis. Arthritis Rheum 2008 ; 58 : 1264-74 .
25. Dieudé P, Guedj M, Wipff J, et al. Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: a new perspective for pulmonary fi brosis. Arthritis Rheum 2009 ; 60 : 225-33 .
26. M achold K P, Stamm TA, Nell VP, et al. Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the fi rst years of disease. Rheumatology (Oxford) 2007 ; 46 : 342-9 .
27. Proudman SM, Conaghan PG, Richardson C, et al. Treatment of poor-prognosis early rheumatoid arthritis. A randomized study of treatment with methotrexate, cyclosporin A, and intraarticular corticosteroids compared with sulfasalazine alone. Arthritis Rheum 2000 ; 43 : 1809-19 .
28. Plant MJ, Jones PW, Saklatvala J, et al. Patterns of radiological progression in early rheumatoid arthritis: results of an 8 year prospective study. J Rheumatol 1998 ; 25 : 417-26 .
29. Wieczorek S, Holle JU, Müller S, et al. A functionally relevant IRF5 haplotype is associated with reduced risk to Wegener's granulomatosis. J Mol Med 2010 ; 88 : 413-21 .
30. van der Helm-van Mil AH, Huizinga TW. Advances in the genetics of rheumatoid arthritis point to subclassifi cation into distinct disease subsets. Arthritis Res Ther 2008 ; 10 : 205 .